HENDRYCHOVA, Tereza, Michal SVOBODA, Josef MALY, Jiri VLCEK, Eva ZIMCIKOVA, Tomas DVORAK, Jaromir ZATLOUKAL, Eva VOLAKOVA, Marek PLUTINSKÝ, Kristián BRAT, Patrice POPELKOVA, Michal KOPECKY, Barbora NOVOTNA and Vladimir KOBLIZEK. Self-Reported Overall Adherence and Correct Inhalation Technique Discordance in Chronic Obstructive Pulmonary Disease Population. FRONTIERS IN PHARMACOLOGY. LAUSANNE: FRONTIERS MEDIA SA, 2022, vol. 13, August 2022, p. 1-11. ISSN 1663-9812. Available from: https://dx.doi.org/10.3389/fphar.2022.860270.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Self-Reported Overall Adherence and Correct Inhalation Technique Discordance in Chronic Obstructive Pulmonary Disease Population
Authors HENDRYCHOVA, Tereza (203 Czech Republic), Michal SVOBODA (203 Czech Republic), Josef MALY (203 Czech Republic), Jiri VLCEK (203 Czech Republic), Eva ZIMCIKOVA (203 Czech Republic), Tomas DVORAK (203 Czech Republic), Jaromir ZATLOUKAL (203 Czech Republic), Eva VOLAKOVA (203 Czech Republic), Marek PLUTINSKÝ (703 Slovakia, belonging to the institution), Kristián BRAT (703 Slovakia, belonging to the institution), Patrice POPELKOVA (203 Czech Republic), Michal KOPECKY (203 Czech Republic), Barbora NOVOTNA (203 Czech Republic) and Vladimir KOBLIZEK (203 Czech Republic, guarantor).
Edition FRONTIERS IN PHARMACOLOGY, LAUSANNE, FRONTIERS MEDIA SA, 2022, 1663-9812.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30203 Respiratory systems
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.600
RIV identification code RIV/00216224:14110/22:00126931
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3389/fphar.2022.860270
UT WoS 000844937200001
Keywords in English COPD; adherence; compliance; application technique; inhalation systems
Tags 14110215, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 18/1/2023 09:52.
Abstract
Background: Adherence to inhaled medication constitutes a major problem in patients with chronic obstructive pulmonary disease (COPD) globally. However, large studies evaluating adherence in its entirety and capturing a large variety of potentially associated factors are still lacking.Objective: To study both elementary types of adherence to chronic inhaled COPD medication in "real-life" COPD patients and to assess relationships with a wide-ranging spectrum of clinical parameters.Methods: Data from the Czech Multicentre Research Database (CMRD) of COPD, an observational prospective study, were used. Overall adherence (OA) was evaluated with Morisky Medication Adherence Scale ((c) MMAS-4) and adherence to an application technique (A-ApplT) with the Five Steps Assessment. Mann-Whitney U test, Spearman's correlation, and logistic regression were used to explore relationships between variables.Results: Data of 546 participants (69.6% of all patients from the CMRD) were analyzed. Two-thirds self-reported optimal OA, but only less than one-third demonstrated A-ApplT without any error. OA did not correlate with A-ApplT. Next, better OA was associated with higher education, a higher number of inhalers, a lower rate of exacerbations, poorer lung function, higher degree of upper respiratory tract symptoms (SNOT-22), absence of depressive symptoms, ex-smoking status, regular mouthwash after inhaled corticosteroids (ICS), and flu vaccination. By contrast, better A-ApplT was associated with a lower number of inhalers, better lung function, and regular mouthwash after ICS. Independent predictors of nonoptimal OA included lower degree of education, absence of flu vaccination, anemia, depression, and peptic ulcer history, whereas independent predictors of lower A-ApplT were lower education, absence of regular mouthwash after ICS, and higher COPD Assessment Test score.Conclusions: Parameters associated with OA and A-ApplT differ, and those associated with both adherence domains are sometimes associated inversely. Based on this finding, we understand these as two separate constructs with an overlap.
Links
LM2018128, research and development projectName: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Acronym: CZECRIN)
Investor: Ministry of Education, Youth and Sports of the CR
15/14/NAP, interní kód MUName: Sledování výskytu deficitu alfa 1 antitrypsinu u pacientů s těžkou formou CHOPN
Investor: Ministry of Health of the CR
5/15/NAP, interní kód MUName: Diagnostika bronchogenního karcinomu u nemocných s těžkou formou CHOPN pomocí výpočetní tomografie
Investor: Ministry of Health of the CR
PrintDisplayed: 18/7/2024 00:27